Company Performance: Bayer's financial results (revenue, profit, growth), and pipeline advancements in pharmaceuticals and agriculture significantly influence investor confidence.

Industry Trends: Developments in the pharmaceutical and agricultural industries, including regulatory changes, competition, and technological advancements, affect Bayer's prospects and share price.

Market Sentiment: General investor mood toward the stock market, pharmaceutical sector, and agrochemical industry plays a crucial role in influencing buyer and seller activity, driving short-term price movements.

Economic Conditions: Macroeconomic factors, such as interest rates, inflation, and GDP growth in key markets impact Bayer's business operations and consequently, its stock valuation.

Currency Exchange Rates: As a global company, fluctuations in currency exchange rates, particularly between the Euro (Bayer's reporting currency) and other currencies, can impact revenue and earnings, thus affecting the stock price.

Regulatory Environment: Changes in regulations related to pharmaceuticals, agriculture, and environmental standards can have a considerable impact on Bayer's profitability and operations, influencing its stock price.

Legal Risks: Ongoing or potential lawsuits, particularly those related to past product liability issues, can introduce uncertainty and affect investor sentiment towards the stock.

Dividends: Changes to Bayer's dividend policy or dividend payouts can impact investor decisions and influence the stock's attractiveness.

Mergers and Acquisitions: Major merger, acquisition, or divestment activity by Bayer can create market uncertainty or optimism, impacting the stock price.

Global Events: Major global events like pandemics, geopolitical tensions, or trade wars can affect overall market sentiment and Bayer's operations, thus influencing its stock price.